Search research articles
Contact Us
Filters
Showing results (1-10 of 191) with videos related to
Page
of 20
Sort By:
European Journal of Hospital Pharmacy : Science and Practice
|
January 9, 2025
Drugs associated with tachyphylaxis: results from a retrospective pharmacovigilance study using disproportionality analysis
Kannan Sridharan
BMC Ophthalmology
|
December 31, 2024
Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Kannan Sridharan
Expert Opinion on Drug Safety
|
October 11, 2025
Angioedema risk of thrombolytics: an integrated assessment using disproportionality analysis of the USFDA adverse event reporting system, case reviews and meta-analysis
Kannan Sridharan
Hospital Pharmacy
|
May 22, 2025
Drug-Associated Tendinopathies and Ligament Disorders: Results from a Retrospective Pharmacovigilance Study Using Disproportionality Analysis
Kannan Sridharan
Current Vascular Pharmacology
|
August 15, 2025
Ductus Arteriosus Variability Linked to Maternal Drug Exposure: Assessment of the USFDA Adverse Event Reporting System using Disproportionality Analysis
Kannan Sridharan
Expert Opinion on Drug Safety
|
February 7, 2025
Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study
Kannan Sridharan
The International Journal of Risk & Safety in Medicine
|
February 23, 2024
Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in Bahrain
Kannan Sridharan
Diseases (Basel, Switzerland)
|
October 28, 2025
Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis
Kannan Sridharan
Current Cardiology Reviews
|
May 13, 2025
Antiplatelet-Proton Pump Inhibitor Interactions and Arterial Thrombotic Events: A Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis
Kannan Sridharan
Expert Opinion on Drug Safety
|
April 26, 2025
Nephrotoxicity risks of colistin-combination therapy: a USFDA adverse event reporting system analysis using disproportionality and interaction assessment
Kannan Sridharan
Page
of 20
Search research articles
Search
Showing results (1-10 of 191) with videos related to
Sort By:
Page
of 20
European Journal of Hospital Pharmacy : Science and Practice
|
January 9, 2025
Drugs associated with tachyphylaxis: results from a retrospective pharmacovigilance study using disproportionality analysis
Kannan Sridharan
BMC Ophthalmology
|
December 31, 2024
Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Kannan Sridharan
Expert Opinion on Drug Safety
|
October 11, 2025
Angioedema risk of thrombolytics: an integrated assessment using disproportionality analysis of the USFDA adverse event reporting system, case reviews and meta-analysis
Kannan Sridharan
Hospital Pharmacy
|
May 22, 2025
Drug-Associated Tendinopathies and Ligament Disorders: Results from a Retrospective Pharmacovigilance Study Using Disproportionality Analysis
Kannan Sridharan
Current Vascular Pharmacology
|
August 15, 2025
Ductus Arteriosus Variability Linked to Maternal Drug Exposure: Assessment of the USFDA Adverse Event Reporting System using Disproportionality Analysis
Kannan Sridharan
Expert Opinion on Drug Safety
|
February 7, 2025
Adverse drug event profile of pharmacotherapies for alcohol use disorder: a retrospective pharmacovigilance disproportionality analysis study
Kannan Sridharan
The International Journal of Risk & Safety in Medicine
|
February 23, 2024
Assessment of drug utilization and potentially inappropriate medications in hemodialysis patients with end-stage renal dysfunction: A study in a tertiary care hospital in Bahrain
Kannan Sridharan
Diseases (Basel, Switzerland)
|
October 28, 2025
Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis
Kannan Sridharan
Current Cardiology Reviews
|
May 13, 2025
Antiplatelet-Proton Pump Inhibitor Interactions and Arterial Thrombotic Events: A Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis
Kannan Sridharan
Expert Opinion on Drug Safety
|
April 26, 2025
Nephrotoxicity risks of colistin-combination therapy: a USFDA adverse event reporting system analysis using disproportionality and interaction assessment
Kannan Sridharan
Page
of 20